Skip to content
HowShorted

Teladoc Health, Inc. short interest in 2019

In 2019, Teladoc Health, Inc.'s disclosed short interest ran from 25.75% of shares outstanding on 15 Jan 2019 to 32.53% on 31 Dec 2019, a change of +6.78 percentage points. The year's high was 37.35% on 15 Oct 2019 and its low 24.16% on 28 Feb 2019, averaging 30.03% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.74 days on 31 Dec 2019. Full history: Teladoc Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Teladoc Health, Inc. in 2019

2019 in figures

Start of year
25.75% (15 Jan 2019)
End of year
32.53% (31 Dec 2019)
Change
+6.78 pp
High
37.35% (15 Oct 2019)
Low
24.16% (28 Feb 2019)
Average
30.03%
Highest days to cover
32.74 (31 Dec 2019)
SEC filings marked
8

Every report in 2019

Teladoc Health, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201925.75%12.63
31 Jan 201925.36%15.14
15 Feb 201925.63%18.13
28 Feb 201924.16%9.5410-K filed, results (8-K)
15 Mar 201925.56%10.17
29 Mar 201926.45%9.72
15 Apr 201929.53%15.58
30 Apr 201926.98%9.1110-Q filed, results (8-K)
15 May 201928.11%13.74
31 May 201926.17%18.60
14 Jun 201927.34%18.42
28 Jun 201926.32%16.58
15 Jul 201928.08%22.58
31 Jul 201928.72%18.0210-Q filed, results (8-K)
15 Aug 201931.60%15.00
30 Aug 201934.08%27.34
13 Sep 201933.27%14.16
30 Sep 201935.85%18.01
15 Oct 201937.35%19.21
31 Oct 201937.34%22.8610-Q filed, results (8-K)
15 Nov 201935.17%20.10
29 Nov 201934.53%19.49
13 Dec 201934.81%21.90
31 Dec 201932.53%32.74

See also: Teladoc Health, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.